Trial intelligence / Profile preview

Ketamine and Hemorrhage Tolerance

NCT03621085Phase 4Completed

Sponsor
UT Southwestern Medical Center
Start
Jun 2018
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ketamine in pain, sponsored by UT Southwestern Medical Center. Started Jun 2018; status: completed.

02

Drugs

ketamine
03

Conditions

pain

Beyond the preview

Go deeper on NCT03621085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03621085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call